Data on Agile Therapeutics, Inc.' Low-Dose Contraceptive Patch (AG200-15) Presented at American College of Obstetricians and Gynecologist Annual Clinical Meeting
5/7/2013 10:13:53 AM
More...
|
Agile Therapeutics, Inc. President and CEO Appointed to Board of BioNJ
2/14/2013 9:17:26 AM
More...
|
Agile Therapeutics, Inc. Chief Medical Officer, Marie Foegh, MD, Named One of New Jersey's Best 50 Women in Business by NJBiz
2/7/2013 9:09:16 AM
More...
|
Agile Therapeutics, Inc. Closes $15 Million Financing Agreement With Oxford Finance
1/3/2013 7:59:34 AM
More...
|
Agile Therapeutics, Inc. to Present at Elsevier Business Intelligence's Therapeutic Area Partnerships
11/29/2012 9:08:22 AM
More...
|
Phase III Data Show Greater Compliance Across Demographic Groups With Agile Therapeutics, Inc.' Contraceptive Patch Compared to an Oral Contraceptive
11/1/2012 11:12:21 AM
More...
|
Agile Therapeutics, Inc. to Present at Biotech 2012
10/22/2012 8:49:42 AM
More...
|
Agile Therapeutics, Inc. Commercial Head to Present at Digital Pharma East
10/16/2012 9:50:45 AM
More...
|
Phase III Data Show Agile Therapeutics, Inc.' Contraceptive Patch Had Greater Compliance Than an Oral Contraceptive
9/24/2012 9:03:33 AM
More...
|
Agile Therapeutics, Inc. to Present at CBI's Forum on Phase II-III Clinical Study Optimization
9/20/2012 9:19:27 AM
More...
|
|